Cognizant Sell-Off Overdone as AI Fears Mask Transformation Upside
Read source articleWhat happened
Cognizant shares have plunged amid fears that AI will commoditize traditional IT services and tighter H-1B visa rules will inflate costs, but the company’s pivot toward higher-value AI implementation, a $2B buyback program, and visible large-deal ramps suggest the sell-off may be excessive. At 12x earnings and an 8.8% free cash flow yield, the stock trades at a discount to peers and its own history, while management’s Project Leap restructuring aims to lift margins to 16.0–16.2% this year. The upcoming closure of the Astreya acquisition and potential revenue acceleration from booked large deals in the second half of 2026 provide concrete catalysts, though execution risks remain around workforce disruption and the pace of AI contract conversion. While the market’s AI anxiety is not unfounded, Cognizant’s exposure to lower-value work appears limited, and its AI-related services could offset disruption. A cautious buy stance is warranted with the stock near the attractive entry zone identified by our analysis.
Implication
The current sell-off prices in a worst-case AI scenario, yet Cognizant’s shift to AI-enabled delivery and its strong large-deal bookings suggest revenue could inflect later this year. A net cash balance sheet and a $2 billion buyback plan provide downside protection, while Project Leap and the Astreya acquisition offer margin and growth levers. The key risk is that restructuring disrupts delivery quality just as new contracts ramp, but early indicators like attrition and RPO should be monitored closely. For patient investors, a 12x P/E and 8.8% FCF yield offers a rare value entry in a sector undergoing rapid change. We recommend accumulating below $55 and trimming above $70, as the market’s panic may recede as second-half results validate the transformation thesis.
Thesis delta
The article reinforces our existing POTENTIAL BUY rating by highlighting that AI and visa fears have overshot, creating a more attractive entry near $54. No change to the core thesis: large-deal conversion, margin recovery, and buybacks remain the primary drivers. However, the H-1B visa tightening adds a new cost headwind worth monitoring in labor-dependent delivery models.
Confidence
Moderate